Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Int J Methods Psychiatr Res. 2017 Oct 15;27(1):10.1002/mpr.1587. doi: 10.1002/mpr.1587

Table 1.

Age-, cohort-, and year-specific risk estimates for newly incident drinking (%) and their 95% confidence intervals. Data from U.S. National Surveys on Drug Use and Health (2002–2014; unweighted n=208,766 12- to 25-year-olds)

12 13 14 15 16 17 18 19 20 21 22–23 24–25
Year Panel 1. Estimates using the age-at-assessment approach

2002 3 (2,4) 8 (7,10) 15 (13,17) 22 (20,25) 27 (25,30) 28 (25,32) 31 (27,35) 23 (19,28) 23 (17,29) 43 (37,49) 11 (8,15) 5 (3,9)
2003 3 (3,5) 9 (7,10) 15 (13,17) 25 (23,28) 25 (22,29) 26 (23,30) 31 (27,36) 27 (21,33) 27 (21,33) 41 (35,48) 17 (13,22) 6 (4,11)
2004 3 (2,4) 8 (6,10) 16 (14,18) 23 (21,25) 27 (24,31) 28 (25,32) 34 (29,39) 26 (22,31) 20 (15,26) 43 (36,49) 14 (10,19) 2 (1,5)
2005 2 (2,3) 8 (6,9) 15 (13,17) 23 (21,25) 27 (24,30) 27 (24,30) 30 (27,34) 29 (25,34) 22 (18,28) 40 (34,47) 11 (8,16) 3 (2,8)
2006 3 (2,3) 7 (6,9) 14 (12,16) 20 (18,22) 26 (23,28) 29 (26,32) 35 (31,38) 31 (26,37) 26 (20,33) 39 (34,45) 16 (11,21) 4 (2,7)
2007 3 (2,4) 7 (6,8) 14 (12,16) 21 (19,24) 25 (22,28) 28 (25,31) 32 (27,36) 27 (22,33) 23 (18,28) 50 (43,57) 14 (11,19) 4 (2,7)
2008 2 (2,3) 6 (5,7) 12 (11,14) 20 (17,23) 25 (23,28) 24 (21,27) 32 (29,35) 29 (25,34) 22 (18,27) 45 (40,50) 16 (12,21) 6 (4,11)
2009 3 (2,4) 7 (6,8) 12 (11,14) 19 (17,21) 27 (24,29) 27 (23,30) 33 (30,37) 30 (26,34) 26 (21,32) 48 (42,54) 17 (13,23) 5 (3,8)
2010 2 (1,3) 6 (5,8) 12 (10,13) 20 (18,22) 24 (21,26) 23 (20,26) 34 (30,39) 27 (24,31) 24 (19,30) 56 (50,62) 17 (13,22) 5 (3,10)
2011 2 (1,3) 6 (5,8) 11 (10,13) 20 (18,22) 23 (21,25) 25 (22,28) 27 (24,30) 25 (21,30) 21 (16,26) 53 (47,58) 20 (16,26) 5 (3,9)
2012 3 (2,4) 5 (4,6) 12 (10,14) 17 (15,19) 21 (19,23) 23 (20,26) 29 (25,33) 27 (22,32) 20 (16,25) 50 (44,56) 23 (18,28) 4 (2,7)
2013 1 (1,2) 4 (3,5) 9 (7,10) 16 (14,18) 24 (22,26) 25 (22,28) 29 (26,33) 25 (22,29) 19 (15,24) 55 (48,62) 19 (14,23) 3 (2,6)
2014 1 (1,2) 4 (3,6) 8 (7,10) 17 (15,18) 21 (19,24) 24 (21,27) 30 (25,35) 23 (18,28) 27 (22,33) 53 (47,59) 20 (16,26) 5 (3,10)

MAS1 2 (2,3) 6 (6,7) 12 (11,14) 20 (19,22) 25 (24,26) 26 (25,27) 31 (30,33) 27 (26,29) 23 (22,25) 47 (44,51) 17 (15,19) 5 (4,5)

Panel 2. Estimates using the age-of-onset approach

2002 5 (4,6) 10 (8,11) 17 (15,19) 23 (20,25) 25 (23,28) 28 (24,32) 28 (25,31) 17 (13,22) 21 (16,26) 43 (38,49) 7 (4,10) 4 (3,8)
2003 5 (4,6) 11 (10,12) 17 (16,19) 25 (22,27) 23 (21,27) 26 (22,30) 29 (25,34) 21 (17,26) 27 (21,33) 40 (33,48) 11 (8,16) 5 (3,9)
2004 5 (4,6) 9 (8,11) 18 (16,20) 23 (21,25) 27 (24,29) 28 (25,32) 29 (25,33) 21 (18,26) 19 (14,25) 43 (37,49) 9 (6,13) 2 (1,5)
2005 4 (4,5) 9 (8,10) 18 (16,20) 23 (21,26) 26 (24,29) 25 (22,28) 30 (26,35) 22 (19,27) 18 (14,24) 41 (35,47) 5 (4,8) 3 (1,7)
2006 4 (3,5) 10 (8,11) 15 (14,17) 22 (20,24) 24 (22,27) 28 (26,31) 33 (29,38) 21 (17,25) 24 (19,31) 40 (35,46) 9 (6,15) 3 (1,6)
2007 4 (3,5) 9 (7,10) 17 (16,19) 21 (18,24) 25 (22,28) 26 (22,29) 30 (27,34) 19 (15,25) 20 (16,26) 51 (44,58) 8 (6,12) 3 (2,6)
2008 4 (3,5) 7 (6,9) 15 (13,17) 23 (20,26) 22 (19,25) 25 (22,28) 30 (27,34) 21 (18,26) 17 (14,21) 47 (41,52) 11 (8,17) 6 (3,10)
2009 4 (3,6) 9 (8,10) 14 (12,16) 21 (19,23) 26 (23,29) 26 (23,29) 33 (29,36) 22 (18,26) 22 (17,28) 51 (45,56) 9 (6,14) 4 (2,7)
2010 3 (2,4) 8 (6,9) 14 (12,16) 22 (19,24) 23 (20,26) 23 (20,26) 32 (28,36) 21 (18,24) 24 (20,29) 57 (50,63) 7 (5,10) 4 (2,8)
2011 3 (2,4) 8 (7,10) 13 (12,15) 21 (19,23) 23 (20,26) 24 (21,27) 26 (23,30) 18 (14,22) 18 (14,23) 55 (50,60) 11 (7,16) 5 (3,8)
2012 3 (2,4) 7 (5,8) 14 (12,15) 18 (16,20) 21 (19,24) 22 (19,26) 29 (25,33) 20 (16,24) 20 (16,24) 51 (45,56) 12 (8,17) 3 (1,5)
2013 2 (2,3) 6 (5,7) 11 (9,12) 19 (17,21) 22 (20,25) 26 (23,29) 27 (24,31) 18 (14,22) 21 (16,26) 56 (49,62) 9 (7,13) 2 (1,5)
2014 2 (1,3) 6 (5,7) 11 (9,12) 18 (16,20) 21 (19,24) 25 (21,29) 28 (24,33) 17 (14,21) 23 (18,28) 56 (50,62) 8 (5,13) 4 (2,9)

MAS1 4 (3,4) 8 (7,9) 15 (13,16) 21 (20,22) 24 (23,25) 26 (24,27) 30 (29,31) 20 (19,21) 21 (19,22) 49 (45,52) 9 (8,10) 4 (3,5)
1

MAS, meta-analysis summary.